{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1390854717827315072.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.20683/jniph.71.1_87"}},{"identifier":{"@type":"NDL_BIB_ID","@value":"032039076"}},{"identifier":{"@type":"URI","@value":"http://id.ndl.go.jp/bib/032039076"}},{"identifier":{"@type":"URI","@value":"https://ndlsearch.ndl.go.jp/books/R000000004-I032039076"}},{"identifier":{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/2022189626"}}],"dc:title":[{"@language":"en","@value":"Medical expenditures for community-acquired pneumococcal disease in Japan"},{"@language":"ja","@value":"日本における市中肺炎球菌感染症による医療費"}],"dc:language":"en","description":[{"type":"abstract","notation":[{"@language":"en","@value":"<p><b>Objectives</b>: The decision-making process for vaccination programs must be informed by cost-effectiveness analyses. This study was performed to quantify the medical expenditures for pneumococcal disease (PD) in Japan.</p><p><b>Methods</b>: Surveillance data from the Japan Nosocomial Infections Surveillance program and insurance claims data were collected from community-acquired PD patients admitted to 29 hospitals in Japan. Patients with positive blood specimens were designated as having invasive PD (IPD). We estimated the medical expenditures incurred during the PD hospitalization episodes.</p><p><b>Results</b>: The study sample comprised 1,358 PD patients from 28 hospitals between April 2015 and September 2017. Of these, 69 were IPD patients and 1,289 were non-IPD patients. The mean medical expenditures (standard deviation) for all PD patients, IPD patients, and non-IPD patients were estimated to be $6,610 ($13,133), $13,975 ($16,415), and $6,216 ($12,823), respectively.</p><p><b>Conclusion</b>: This study is the first to quantify the medical expenditures for community-acquired PD in Japan.</p>"},{"@language":"ja","@value":"<p><b>目的</b>：ワクチン接種プログラムの意思決定プロセスには，費用対効果評価が必要である．本研究の目的は，市中肺炎球菌感染症（PD）による医療費を推定することである．</p><p><b>方法</b>：日本の29のDPC対象病院に入院した市中肺炎球菌感染症患者について，厚生労働省院内感染対策サーベイランス事業（JANIS）の検査部門データとDPCデータを突合した．JANISデータにおいて血液検体が陽性の患者を侵襲性肺炎球菌感染症（IPD）と定めた．市中肺炎球菌感染症症例の医療費を推定した．</p><p><b>結果</b>：解析対象症例は28病院における1,358症例である．IPD症例は69症例，非IPD症例は1,289症例であった．全PD症例，IPD症例，非IPD症例における平均医療費（標準偏差）は，それぞれ6,610ドル（13,133ドル），13,975ドル（16,415ドル），6,216ドル（12,823ドル）と推定された．</p><p><b>結論</b>：本研究は日本において市中肺炎球菌感染症による医療費を初めて定量化することができた．</p>"}],"abstractLicenseFlag":"allow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420282801185293568","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"30572119"},{"@type":"NRID","@value":"1000030572119"},{"@type":"ORCID","@value":"0000-0003-1120-1548"},{"@type":"NRID","@value":"9000251869766"},{"@type":"NRID","@value":"9000016608043"},{"@type":"NRID","@value":"9000006958198"},{"@type":"NRID","@value":"9000403105542"},{"@type":"NRID","@value":"9000240077386"},{"@type":"NRID","@value":"9000262372737"},{"@type":"NRID","@value":"9000262372710"},{"@type":"NRID","@value":"9000025025878"},{"@type":"NRID","@value":"9000240077462"},{"@type":"NRID","@value":"9000411373529"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/haruhisafukuda"}],"foaf:name":[{"@language":"en","@value":"FUKUDA Haruhisa"},{"@language":"ja","@value":"福田 治久"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学大学院医学研究院医療経営・管理学講座"},{"@language":"en","@value":"Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences"}]},{"@id":"https://cir.nii.ac.jp/crid/1410854717827314944","@type":"Researcher","foaf:name":[{"@language":"en","@value":"ONIZUKA Hiroaki"},{"@language":"ja","@value":"鬼塚 浩明"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学共創学部"},{"@language":"en","@value":"Department of Interdisciplinary Science and Innovation, Kyushu University School of Interdisciplinary Science and Innovation"}]},{"@id":"https://cir.nii.ac.jp/crid/1410854717827314945","@type":"Researcher","foaf:name":[{"@language":"en","@value":"MURATA Fumiko"},{"@language":"ja","@value":"村田 典子"}],"jpcoar:affiliationName":[{"@language":"ja","@value":"九州大学大学院医学研究院医療経営・管理学講座"},{"@language":"en","@value":"Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13476459"},{"@type":"EISSN","@value":"24320722"},{"@type":"NDL_BIB_ID","@value":"000000417205"},{"@type":"ISSN","@value":"13476459"},{"@type":"LISSN","@value":"13476459"},{"@type":"NCID","@value":"AA11751510"}],"prism:publicationName":[{"@language":"ja","@value":"保健医療科学"},{"@language":"en","@value":"Journal of the National Institute of Public Health"},{"@language":"en","@value":"J NIPH"}],"dc:publisher":[{"@language":"en","@value":"National Institute of Public Health"},{"@language":"ja","@value":"国立保健医療科学院"}],"prism:publicationDate":"2022-02-28","prism:volume":"71","prism:number":"1","prism:startingPage":"87","prism:endingPage":"91"},"url":[{"@id":"http://id.ndl.go.jp/bib/032039076"},{"@id":"https://ndlsearch.ndl.go.jp/books/R000000004-I032039076"},{"@id":"https://search.jamas.or.jp/link/ui/2022189626"}],"availableAt":"2022-02-28","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=%E8%82%BA%E7%82%8E%E7%90%83%E8%8F%8C%E6%84%9F%E6%9F%93%E7%97%87","dc:title":"肺炎球菌感染症"},{"@id":"https://cir.nii.ac.jp/all?q=%E4%BE%B5%E8%A5%B2%E6%80%A7%E8%82%BA%E7%82%8E%E7%90%83%E8%8F%8C%E6%84%9F%E6%9F%93%E7%97%87","dc:title":"侵襲性肺炎球菌感染症"},{"@id":"https://cir.nii.ac.jp/all?q=%E5%8C%BB%E7%99%82%E8%B2%BB","dc:title":"医療費"},{"@id":"https://cir.nii.ac.jp/all?q=%E5%B8%82%E4%B8%AD%E6%84%9F%E6%9F%93","dc:title":"市中感染"},{"@id":"https://cir.nii.ac.jp/all?q=Streptococcus%20pneumoniae","dc:title":"Streptococcus pneumoniae"},{"@id":"https://cir.nii.ac.jp/all?q=invasive%20pneumococcal%20disease","dc:title":"invasive pneumococcal disease"},{"@id":"https://cir.nii.ac.jp/all?q=medical%20expenditures","dc:title":"medical expenditures"},{"@id":"https://cir.nii.ac.jp/all?q=community-acquired%20infection","dc:title":"community-acquired infection"}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2009236473"},{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R000000004-I032039076"}]}